Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/18626
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKaba, S. E.en
dc.contributor.authorLangford, L. A.en
dc.contributor.authorYung, W. K.en
dc.contributor.authorKyritsis, A. P.en
dc.date.accessioned2015-11-24T18:53:56Z-
dc.date.available2015-11-24T18:53:56Z-
dc.identifier.issn0167-594X-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/18626-
dc.rightsDefault Licence-
dc.subjectAdulten
dc.subjectAntineoplastic Agents/*therapeutic useen
dc.subjectBrain Neoplasms/*drug therapy/pathologyen
dc.subjectGanglioglioma/*drug therapy/pathologyen
dc.subjectHumansen
dc.subjectIsotretinoin/*therapeutic useen
dc.subjectMagnetic Resonance Imagingen
dc.subjectMaleen
dc.subjectNeoplasm Recurrence, Local/*drug therapy/pathologyen
dc.titleResolution of recurrent malignant ganglioglioma after treatment with cis-retinoic aciden
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/8865003-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate1996-
heal.abstractGanglioglioma is an uncommon brain tumor with glial and neuronal cellular components and a somewhat benign course. We are presenting an unusual case of ganglioglioma with malignant transformation in both cellular components associated with an aggressive clinical course. An almost complete resolution of the recurrent progressing tumor was achieved after treatment with cis-retinoic acid (cRA) as a single agent. A possible differential effect of cRA on the neuronal component of the tumor is suggested.en
heal.journalNameJ Neurooncolen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons